Dr. Barry Gustin - Medical-Legal Expert Services

About Dr. Gustin


Dr_Barry_GustinDr. Gustin is residency-trained and board-certified in Emergency Medicine and Forensic Medicine and has been actively practicing in the fields of Emergency Medicine, Toxicology, and Forensic Medicine for more than 25 years.  He has additional training and expertise in Medical, Occupational, and Environmental Toxicology and has Masters Degrees in Biochemistry, Metabolism and Nutrition, as well as Toxicology and Public Health. He is the primary founder of the American College of Forensic Medicine which currently has more than 2,000 members.

Dr. Gustin has reviewed thousands of medical malpractice, personal injury, criminal, and toxicology cases during his career.  Dr. Gustin also has substantial testimony experience as an expert witness.

You can access Dr. Gustin's medical-legal experience by requesting a FREE phone or email consultation now. To review all the Services he offers, please click here.

Dr. Gustin's education, training, and experience qualifies him to evaluate and testify regarding a broad range of cases, in the following medical and toxicology specialty areas:

  • Emergency Medicine, medical, surgical, pediatric
  • Emergency Medical Ambulance Services (EMS)
  • Trauma and Critical Care
  • Forensic Toxicology
  • Medical Toxicology and Poisoning (eg: accidental overdose, carbon monoxide poisoning, and all other product and drug exposures)
  • Occupational and Environmental Toxicology
  • Mechanisms and Forces of Injury in Criminal Cases
  • Substance Abuse and Drug Addiction (Drug and Alcohol, including DUI)
  • Electrical Injury
  • Pharmaceutical Medicine (Drug-Drug interactions, Drug-Disease Interactions, Overdose, Unsafe poorly tested Drugs, Adverse Drug Reactions)
  • Flight, Travel, and Wilderness Medicine
  • Hospital Malpractice
  • Public Health (eg: Legionnaire's Disease, Outbreak Diseases, Food Poisoning, and Waterborne Diseases)
  • Legal Medicine (standard of care, evidence-based causation, medical ethics)

His primary areas of specialization are Emergency Medicine and Toxicology.

A partial list of cases Dr. Gustin has consulted on include:  drugs of abuse including Methamphetamine, Cocaine, Opiates, and Alcohol, occupational chemical poisonings including toluene, benzene, isocyanates, other solvents, heavy metals including lead, carbon monoxide, and cyanide, occupational and travel-related infectious illness including Legionnaire's disease, MRSA, skin infections, bacterial enteritis, misdiagnosis and delayed treatments in the ER, civil rights cases, environmental exposure cases including contaminated water and sewage exposure.

Dr. Gustin's expert opinions will comply with ACEP (American College of Emergency Physicians) guidelines for Expert Witness Testimony: See: http://www.acep.org/practres.aspx?id=29446 ; the ACT (American College of Toxicology); and ACFE (American College of Forensic Examiners) Creed of Ethics.  See: http://www.acfei.com/about_acfei/creed/ 

Office: 2928 Derby Street, Berkeley, CA 94705
Tele: 510-549-1041
Fax: 510-549-3268
Email: Click here to email Dr. Gustin


Ecstasy Use Increases Dramatically

Print E-mail
Friday, 10 January 2014 23:00

As Emergency Departments swell while suffering the repercussions of the Affordable Healthcare Act, our nation's youth increase their use of mind-altering drugs, in particular, Ecstasy (Mollys).

The number of emergency department (ED) visits related to the use of Ecstasy (MDMA) (3,4-methylenedioxymethamphetamine) has increased by a staggering 128% in just 6 years, new research shows.

Also known as Ecstasy or Molly, a new report from the Substance Abuse and Mental Health Services Administration (SAMHSA) shows that MDMA-related visits among individuals younger than 21 years jumped from 4460 in 2005 to 10,176 in 2011.

In addition, 33% of ED visits involving MDMA use in this patient population also involved alcohol use.

"These findings raise concerns about the increase in popularity of this potentially harmful drug, especially in young people. Ecstasy is a street drug that can include other substances that can render it even more potentially harmful. We need to increase awareness about this drug's dangers and take other measures to prevent its use," Peter Delany, MD, SAMSHA's director of the Center for Behavioral Health and Statistics and Quality, said in a release.

MDMA has both stimulant and hallucinogenic properties. Although it is usually taken by mouth, it can also be snorted or smoked. The drug produces feelings of increased energy and euphoria and distorts users' sense and perception of time.

The report authors also note that the drug can produce a variety of negative health effects, including anxiety and confusion, that can last a week or longer. In addition, it has been associated with hypertension, as well as renal and cardiac failure.

The increase in this population is "a cause for concern due to the serious health risks involved with Ecstasy use and the higher potential for abuse when Ecstasy is mixed with alcohol," the report authors write.

The full report is available on the SAMSHA Web site.


Elevated Glucose in the ER

Print E-mail
Wednesday, 18 December 2013 11:13

Over the past few years advancements have been made in the approach to, and management of, elevated blood glucose.  In the emergency room, elevated blood glucose (hyperglycemia) is commonly encountered.  Often times, patients who present with unrelated problems are coincidentally found to have elevated blood glucose.  Many emergency physicians dismiss this finding as a chronic finding and therefore, do not investigate further.  But this is a mistake that often results in an adverse patient outcome, and later a medical-legal inquiry and possibly a medical malpractice lawsuit.

Elevated blood glucose can be a tip-off that there are serious metabolic abnormalites present.  A detailed investigation is warranted in the ER because many of these patients are asymptomatic and will not seek follow-up medical care until they become symptomatic, by which time their condition may be far advanced.  The following review article on the approach to hyperglycemia in the ER is current and represents the standard of care approach to these patients.

Read more... [Elevated Glucose in the ER]

FDA Revises AMBIEN guidelines

Print E-mail
Wednesday, 15 May 2013 16:49

Ambien is the most common sleeping medication at the present time.  Unfortunately, although Ambien is usually quite effective at facilitating sleep, it also has been found to have several disturbing side effects, including tolerance, addiction, and somambulism.  Recently the FDA has revised its dosing guidelines on how the medication should be used.  The news brief follows:

Read more... [FDA Revises AMBIEN guidelines]

Problems With Ambien

Print E-mail
Monday, 06 May 2013 15:59

Ambien (zolpidem) is currently the most commonly used sleeping medication on the market. Most physicians believe, unknowingly, that it can be prescribed with impunity.  This is not the case.  Ambien has many side effects that have resulted in a big increase in visits to emergency departments.

Read more... [Problems With Ambien]

Amitiza for Opioid-induced Constipation

Print E-mail
Tuesday, 30 April 2013 23:25

The FDA finally approved a new drug which ameliorates the severe constipation that accompanies the use of Opiates.  Constipation is one of the main side effects that causes individuals to stop Opiate medication prematurely without any other option for their pain.  This addition to treatment with opiates is a notable advancement.

Read more... [Amitiza for Opioid-induced Constipation]

Zithromax and Sudden Death

Print E-mail
Tuesday, 19 March 2013 17:50

At one time or another, most of us have taken the antibiotic, Zithromax.  It is one of the most commonly prescribed medications for conditions including bronchitis, pharyngitis, sinusitis, and others.  The discussion that follows has to do with Zithromax's side-effects, some of which are potentially life-threatening.  Recently, I have seen a case in my emergency room of sudden cardiac arrest secondary to the cardiac effects of Zithromax.  The FDA has recently warned of this phenomenon.

Read more... [Zithromax and Sudden Death]

2013 Review of Food Poisoning

Print E-mail
Wednesday, 30 January 2013 14:51

The following article on food poisoning and foodborne outbreak disease was obtained from a recent issue of emedicine #175569.  It is an overview that covers major topics and issues.  It does not address travel medicine.  But it would have direct relevance to community acquired disease, assessments for such diseases, and surveillance.

Read more... [2013 Review of Food Poisoning]

2013 Review of Food Poisoning

Print E-mail
Wednesday, 30 January 2013 14:51

The following article on food poisoning and foodborne outbreak disease was obtained from a recent issue of emedicine #175569.  It is an overview that covers major topics and issues.  It does not address travel medicine.  But it would have direct relevance to community acquired disease, assessments for such diseases, and surveillance.

Read more... [2013 Review of Food Poisoning]

Emergency Medicine Malpractice Defense

Print E-mail
Friday, 28 December 2012 10:25

A recent article appeared in the Journal of Emergency Medicine that addresses medical malpractice, medical malpractice prevention, improved quality of care and documentation, and medical malpractice defense.  Specific examples are given to illustrate general concepts.  Since the article has particular relevance to the practice of emergency medicine, I include it here on my blog for those who are interested in reading it.

Read more... [Emergency Medicine Malpractice Defense]

FDA Warning Regarding Sodium Oxybate for daytime drowsiness

Print E-mail
Thursday, 27 December 2012 21:57

The US Food and Drug Administration (FDA) has issued a warning against use of alcohol and central nervous system depressant drugs (CNS), such as benzodiazepines and opioids, with sodium oxybate ( Xyrem, Jazz Pharmaceuticals) because of the risk for impaired consciousness and respiratory depression.

The drug, used to reduce episodes of cataplexy and treat daytime sleepiness in patients with narcolepsy, is already contraindicated for use with insomnia drugs. The new contraindications are reflected in labeling changes for the drug.

Read more... [FDA Warning Regarding Sodium Oxybate for daytime drowsiness]
  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  4 
  •  5 
  •  6 
  •  7 
  •  8 
  •  9 
  •  Next 
  •  End 
  • »

Page 1 of 9
You are here: Home
Copyright © 2010 - www.emergencymedicineexpert.com
mdaad free xxx movies vids xxx dvd movies